Faeth Therapeutics, Inc. (FTH) stock
FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$9.04−0.24 (-2.59%)
Close on Nov 17, 2026Market cap $233.60MP/E –Yield –
Faeth Therapeutics r&d expenses
Research and development expenses are spending on new products and technology.
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2021 | Mar 31, 2021 | $3.37M | – |
| Q1 FY2020 | Mar 31, 2020 | $2.20M | – |
See a number that looks wrong?